BRIGHT TECHNOLOGIES LIMITED

Company number 03416486

3 active persons with significant control / 0 active statements

Lablogic Group Holdings Limited (Active)

• Correspondence address: Innovation House, Europa View, Sheffield, England, S9 1XH
• Notified on: 28 July 2023
• Governing law: Companies Act 2006
• Legal form: Limited Company
• Place registered: United Kingdom Companies Registry
• Registration number: 07762538
• Incorporated in: United Kingdom
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%

Medical Equipment Manufacturers (Sheffield) Limited (Active)

• Correspondence address: Marland House, 13 Huddersfield Road, Barnsley, South Yorkshire, United Kingdom, S70 2LW
• Notified on: 17 May 2021
• Governing law: Companies Act 2006
• Legal form: Limited Company
• Place registered: United Kingdom Companies Registry
• Registration number: 01747261
• Incorporated in: United Kingdom
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%

Mrs Nicola Victoria Rodgers (Active)

• Correspondence address: 3 Rose Hill Drive, Mosborough, Sheffield, England, S20 5PN
• Notified on: 6 April 2016
• Date of birth: April 1971
• Nationality: British
• Country of residence: England
• Nature of control: Has significant influence or control

Mr Stephen John Anderson (Ceased)

• Correspondence address: 31 Boscombe Road, Worksop, England, S81 7SB
• Notified on: 6 April 2016
• Ceased on: 28 July 2023
• Date of birth: September 1962
• Nationality: British
• Country of residence: England
• Nature of control: Ownership of shares – More than 25% but not more than 50%

Mr Peter Staniforth (Ceased)

• Correspondence address: 40 Clowne Road, Barlborough, Chesterfield, England, S43 4EJ
• Notified on: 6 April 2016
• Ceased on: 4 June 2021
• Date of birth: November 1953
• Nationality: British
• Country of residence: England
• Nature of control: Ownership of shares – More than 25% but not more than 50%